The Technology Behind Bluebird Bio - Bloomberg

Bloomberg
The Technology Behind Bluebird Bio
Bloomberg
Bluebird Bio CEO Nick Leschly discusses gene therapy, Boston's biotech scene, and venture capital with Bloomberg's Caroline Hyde on "Bloomberg Technology" at the Museum of Science in Boston on May 9. (Source: Bloomberg) ...